295 related articles for article (PubMed ID: 10852689)
21. Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients.
Atalay H; Solak Y; Acar K; Govec N; Turk S
Hemodial Int; 2011 Jul; 15(3):374-8. PubMed ID: 21564503
[TBL] [Abstract][Full Text] [Related]
22. Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia.
Dossabhoy NR; Turley S; Gascoyne R; Tapolyai M; Sulaiman K
Ren Fail; 2014 Aug; 36(7):1033-7. PubMed ID: 24845687
[TBL] [Abstract][Full Text] [Related]
23. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
[TBL] [Abstract][Full Text] [Related]
24. Use of intravenous iron supplementation in chronic kidney disease: an update.
Macdougall IC; Geisser P
Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
[TBL] [Abstract][Full Text] [Related]
25. A trial of two iron-dextran infusion regimens in chronic hemodialysis patients.
Agarwal R; Davis JL; Hamburger RJ
Clin Nephrol; 2000 Aug; 54(2):105-11. PubMed ID: 10968685
[TBL] [Abstract][Full Text] [Related]
26. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
Mircescu G; Gârneata L; Capusa C; Ursea N
Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
[TBL] [Abstract][Full Text] [Related]
27. [Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients].
Reynoso-Gómez E; Salinas-Rojas V; Lazo-Langner A
Rev Invest Clin; 2002; 54(1):12-20. PubMed ID: 11995402
[TBL] [Abstract][Full Text] [Related]
28. Hemoglobin control, ESA resistance, and regular low-dose IV iron therapy: a review of the evidence.
Singh A
Semin Dial; 2009; 22(1):64-9. PubMed ID: 19175537
[TBL] [Abstract][Full Text] [Related]
29. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
Plummer ES; Crary SE; McCavit TL; Buchanan GR
Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis.
Susantitaphong P; Alqahtani F; Jaber BL
Am J Nephrol; 2014; 39(2):130-41. PubMed ID: 24513913
[TBL] [Abstract][Full Text] [Related]
31. Acute injury with intravenous iron and concerns regarding long-term safety.
Bishu K; Agarwal R
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of total dose iron dextran administration in patients on home renal replacement therapies.
Sloand JA; Shelly MA; Erenstone AL; Schiff MJ; Talley TE; Dhakal MP
Perit Dial Int; 1998; 18(5):522-7. PubMed ID: 9848632
[TBL] [Abstract][Full Text] [Related]
33. [Principles of iron therapy in hemodialysis patients].
Basić-Jukić N; Kes P; Jurić I
Acta Med Croatica; 2006 Dec; 60(5):457-62. PubMed ID: 17217102
[TBL] [Abstract][Full Text] [Related]
34. Stability of iron dextran (DexFerrum) in peritoneal dialysis bags.
Manley HJ; Grabe DW; Bailie GR; Norcross ML
Perit Dial Int; 1998; 18(5):538-40. PubMed ID: 9848638
[No Abstract] [Full Text] [Related]
35. Use of iron sucrose in dialysis patients sensitive to iron dextran.
Haddad A; Abbadi R; Marji A
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):208-11. PubMed ID: 19237805
[TBL] [Abstract][Full Text] [Related]
36. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia?
Deaver K; Bennington L
Nephrol Nurs J; 2006; 33(4):430-7; quiz 438. PubMed ID: 17002001
[TBL] [Abstract][Full Text] [Related]
37. [Optimizing iron therapy in hemodialysis: a prospective long term clinical study].
Siga E; Aiziczon D; Díaz G
Medicina (B Aires); 2011; 71(1):9-14. PubMed ID: 21296714
[TBL] [Abstract][Full Text] [Related]
38. Iron overload in the erythropoietin era.
Robbins KC
Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
[TBL] [Abstract][Full Text] [Related]
39. Intravenous iron dextran for severe refractory restless legs syndrome.
Ondo WG
Sleep Med; 2010 May; 11(5):494-6. PubMed ID: 20371212
[TBL] [Abstract][Full Text] [Related]
40. The treatment of anemia in peritoneal dialysis patients.
Lacson E; Diaz-Buxo JA
Clin Nephrol; 2001 Dec; 56(6):415-27. PubMed ID: 11770793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]